Compare ETFs
Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.
Side by side
| Measure | IDNAiShares Genomics Immunology and Healthcare ETF | VTVanguard Total World Stock Index ETF |
|---|---|---|
| Market | USNYSE Arca | USNYSE Arca |
| Issuer | iShares | Vanguard |
| Asset class | Equity · Global | Equity · Global |
| Expense ratio | 0.47%Expense ratio, filed 21 Nov 2025 | 0.06%Expense ratio, filed 27 Feb 2026 |
| Net assets | $190.9MAs of 31 Jul 2026 | $97.9BAs of 31 Jul 2026 |
| Holdings | 61As of 31 Jul 2026 | 10,100As of 31 Jul 2026 |
| 12-month distribution yield | 0.67% | 1.53% |
| Distributions | Twice a year$0.2800 in 12 months | Quarterly$2.4130 in 12 months |
| Last price | $42.0520 Oct 2026, 15:04 UTC | $157.8020 Oct 2026, 20:00 UTC |
Holdings overlap
Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.
| Fund | IDNA | VT |
|---|---|---|
| IDNA | Same fund | 1.1%at least |
| VT | 1.1%at least | Same fund |
IDNA and VT
- Weighted overlap
- 1.1%
- Holdings in common
- 14
- IDNA holdings also in VT
- 25.0% by count
- VT holdings also in IDNA
- 0.7% by count
| Holding | Weight in IDNA | Weight in VT | Overlap | Matched by |
|---|---|---|---|---|
| MERCK & CO., INC. US58933Y1055 | 3.91% | 0.28% | 0.28% | ISIN |
| Roche Holding AG CH1499059983 | 3.85% | 0.24% | 0.24% | ISIN |
| VERTEX PHARMACEUTICALS INCORPORATED US92532F1003 | 3.87% | 0.10% | 0.10% | ISIN |
| GSK PLC GB00BN7SWP63 | 3.63% | 0.09% | 0.09% | ISIN |
| SANOFI SA FR0000120578 | 3.46% | 0.08% | 0.08% | ISIN |
| REGENERON PHARMACEUTICALS, INC. US75886F1075 | 4.35% | 0.07% | 0.07% | ISIN |
| Bayer AktiengesellschaftBAYER AG DE000BAY0017 | 4.81% | 0.05% | 0.05% | ISIN |
| Takeda Pharmaceutical Company LimitedTAKEDA PHARMACEUTICAL CO LTD JP3463000004 | 4.05% | 0.05% | 0.05% | ISIN |
| REVOLUTION MEDICINES, INC. US76155X1000 | 4.55% | 0.03% | 0.03% | ISIN |
| INCYTE CORPORATION US45337C1027 | 4.23% | 0.02% | 0.02% | ISIN |
How overlap is measured
Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.
Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.
Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.
The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.
Currency exposure
| Currency | IDNA | VT |
|---|---|---|
| US dollar (USD) | 77.5% | 62.9% |
| Euro (EUR) | 12.6% | 7.3% |
| Japanese yen (JPY) | 6.0% | 5.8% |
| British pound (GBP) | 3.7% | 3.2% |
| Swiss franc (CHF) | 3.8% | 2.0% |
| Hong Kong dollar (HKD) | 2.3% | 2.4% |
| Danish krone (DKK) | 4.2% | Below the top 12 or none |
| New Taiwan dollar (TWD) | <0.1% | 3.1% |
| Canadian dollar (CAD) | Below the top 12 or none | 3.0% |
| South Korean won (KRW) | 0.3% | 2.2% |